ESMO整合肿瘤与姑息治疗指定中心的姑息治疗项目「临界质量」调查
该调查向全部184个ESMO指定中心发放78题电子问卷,应答率83%(152/184)。结果显示指定中心姑息治疗基础设施水平较高,晚期癌症患者死亡前接受姑息治疗咨询的估计比例为70%(IQR 28-80%),门诊咨询中位时间为死亡前90天(IQR 40-150天),住院患者为21天(IQR 14-45天)。
要点
- 152个ESMO指定中心应答,90%设住院咨询团队,89%设门诊姑息治疗门诊。
- 晚期癌症患者死亡前接受姑息治疗咨询的估计比例为70%(IQR 28-80%)。
- 39%的中心提供姑息治疗专科培训,32%要求肿瘤专科受训者轮转姑息治疗。
核心结论
- ESMO指定中心具有较高水平的姑息治疗基础设施,并为大部分晚期癌症患者提供姑息治疗服务。
- 调查支持ESMO指定的13项标准为整合提供了稳健框架,在认证前促进了对部分姑息治疗项目的资源投入,并提高了临床医生、受训者和患者对姑息治疗的兴趣。
研究设计与样本
- 向全部184个ESMO整合肿瘤与姑息治疗指定中心发放包含78个问题的电子问卷调查。
- 问卷涵盖指定中心特征、姑息治疗临床项目(结构、流程和结局)、肿瘤内科医生提供的初级姑息治疗、教育、研究及对ESMO指定中心项目的态度和信念。
- 应答率为83%(152/184)。
主要发现
- 115个(76%)ESMO指定中心来自欧洲,87个(57%)为三级医疗中心。
- 136个(90%)中心设有住院咨询团队,135个(89%)设有门诊姑息治疗门诊,107个(71%)设有专用急性护理床位,75个(50%)提供社区姑息治疗。
- 晚期癌症患者死亡前接受姑息治疗咨询的估计比例为70%(IQR 28-80%),门诊患者咨询中位时间为死亡前90天(IQR 40-150天),住院患者为21天(IQR 14-45天)。
- 118个(78%)ESMO指定中心报告在肿瘤门诊提供常规症状筛查,30%的患者由其肿瘤医生记录了临终讨论。
关键数值与推荐
- ESMO指定中心应答率83%(152/184)。
- 晚期癌症患者死亡前接受姑息治疗咨询的估计比例为70%(IQR 28-80%)。
- 门诊患者姑息治疗咨询中位时间为死亡前90天(IQR 40-150天),住院患者为21天(IQR 14-45天)。
临床怎么用
- ESMO指定中心可作为整合肿瘤与姑息治疗的参考模式,其姑息治疗临床服务覆盖住院咨询、门诊门诊、急性护理床位及社区服务等多种形式。
- 调查结果支持ESMO指定的13项标准作为整合框架,并可促进认证前的资源投入及提高各方对姑息治疗的兴趣。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The ESMO Designated Centres (ESMO-DCs) of Integrated Oncology and Palliative Care (PC) Incentive Programme has grown steadily. We aimed to characterise the level of PC clinical services, education and research at ESMO-DCs. METHODS: We sent all 184 ESMO-DCs an electronic survey consisting of 78 questions examining the DC characteristics, palliative care clinical programme (structure, processes, and outcomes), primary PC delivery by oncologists, education, research and attitudes and beliefs towards the ESMO-DC programme. RESULTS: The response rate was 83% (152/184). 115 (76%) ESMO-DCs were from Europe, 87 (57%) were tertiary care centres. 136 (90%) had inpatient consultation teams, 135 (89%) had outpatient PC clinics, 107 (71%) had dedicated acute care beds, and 75 (50%) offered community-based PC. An estimated 70% (interquartile range [IQR] 28-80%) of patients with advanced cancer had a PC consultation before death, occurring 90 days before death (median, IQR 40-150 days) for outpatients and 21 days (IQR 14-45 days) for inpatients. 59 (39%) offered PC fellowship programme; 47 (32%) had mandatory PC rotations for oncology fellows. Ninety-nine (65%) had double-boarded palliative oncologists. 118 (78%) of the ESMO-DCs reported that routine symptom screening was offered in the oncology clinic and 30% of patients had documented end-of-life discussions by their oncologists. Most centres (>80%) perceived the ESMO-DC programme to increase their status. CONCLUSIONS: The ESMO-DCs had a high level of PC infrastructure and provided access to a large proportion of patients with advanced cancer. The survey supports that the 13 criteria required for ESMO designation set a robust framework for integration, stimulated investment of resources into some palliative care programmes prior to accreditation, and raised the interest about palliative care among clinicians, trainees and patients.
引用
- Hui D, Cherny N, Latino N, et al. The 'critical mass' survey of palliative care programme at ESMO designated centres of integrated oncology and palliative care. Ann Oncol. 2017. PMID: 28911084. doi:10.1093/annonc/mdx280
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。